Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Revenue (2021 - 2025)

Historic Revenue for Krystal Biotech (KRYS) over the last 4 years, with Q3 2025 value amounting to $97.8 million.

  • Krystal Biotech's Revenue rose 1664.94% to $97.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $373.2 million, marking a year-over-year increase of 5446.2%. This contributed to the annual value of $290.5 million for FY2024, which is 47300.79% up from last year.
  • According to the latest figures from Q3 2025, Krystal Biotech's Revenue is $97.8 million, which was up 1664.94% from $96.0 million recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Revenue ranged from a high of $97.8 million in Q3 2025 and a low of -$1.5 million during Q1 2021
  • Over the past 4 years, Krystal Biotech's median Revenue value was $77.1 million (recorded in 2024), while the average stood at $62.2 million.
  • Its Revenue has fluctuated over the past 5 years, first surged by 87990.88% in 2024, then surged by 1664.94% in 2025.
  • Quarter analysis of 4 years shows Krystal Biotech's Revenue stood at -$1.5 million in 2021, then soared by 2924.66% to $42.1 million in 2023, then skyrocketed by 116.2% to $91.1 million in 2024, then increased by 7.34% to $97.8 million in 2025.
  • Its Revenue was $97.8 million in Q3 2025, compared to $96.0 million in Q2 2025 and $88.2 million in Q1 2025.